Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction (Q35888435)

10 August 2017

1 reference

title

Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction (English)

1 reference

intrauterine growth restriction

10 August 2017

0 references

0 references

1 reference

Marinus A Blankenstein

4

0 references

author name string

May Lee Tjoa

1

1 reference

10 August 2017

Cees B M Oudejans

2

1 reference

10 August 2017

John M G van Vugt

3

1 reference

10 August 2017

Inge J van Wijk

5

1 reference

10 August 2017

1 January 2004

1 reference

Hypertension in Pregnancy

10 August 2017

1 reference

10 August 2017

23

1 reference

10 August 2017

2

1 reference

10 August 2017

171-189

1 reference

Treatment of hypertension in pregnant women

10 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Pre-eclampsia: more than pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

The vascular endothelial growth factor family: signalling for vascular development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Selectins in normal pregnancy, pre-eclampsia and missed abortus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Serum leptin levels and the severity of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Multiple marker second trimester serum screening for pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Intrauterine growth restriction without pre-eclampsia and associated changes in serum inhibin A and activin A levels: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Inflammatory markers and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

A regulatory role for neurokinin B in placental physiology and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Presence of fetal DNA in maternal plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Fetal DNA in maternal plasma: emerging clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

The pathogenesis of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Apoptosis in the placenta of pregnancies complicated with IUGR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

mRNA of placental origin is readily detectable in maternal plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Placental peptides as markers of gestational disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Elevated C-reactive protein levels in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FPRG-120028292

21 January 2018

Identifiers

DOI

10.1081/PRG-120028292

1 reference

10 August 2017

1 reference